9-bromo-10-(4-phenylnaphthyl-1-yl)anthracene | CAS:944801-28-9

We serve 9-bromo-10-(4-phenylnaphthyl-1-yl)anthracene CAS:944801-28-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
9-bromo-10-(4-phenylnaphthyl-1-yl)anthracene

Chemical Name:9-bromo-10-(4-phenylnaphthyl-1-yl)anthracene
CAS.NO:944801-28-9
Synonyms:BA1NP
9-bromo-10-(4-phenylnaphthyl-1-yl)anthracene
Molecular Formula:C30H19Br
Molecular Weight:459.37600
 
Specification:
Appearance:White powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates



Contact us for information like 9-bromo-10-(4-phenylnaphthyl-1-yl)anthracene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,BA1NP physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9-bromo-10-(4-phenylnaphthyl-1-yl)anthracene Use and application,9-bromo-10-(4-phenylnaphthyl-1-yl)anthracene technical grade,usp/ep/jp grade.


Related News: f you’ve traveled in or transited through mainland China, you won’t be allowed into New Zealand unless you’re a New Zealand national.methyl (2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoate,hydrochloride manufacturer Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.D-Norvaline supplier An active pharmaceutical ingredient (API) is a substance, or a mixture of ingredients, combined in the manufacture of a pharmaceutical or drug.(2'R)-2'-Deoxy-2'-fluoro-2'-methyl-uridine vendor The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.The patient, who arrived from Wuhan, is “stable and under medical care,” the ministry said in a statement, adding there is “no cause for concern” for the public.